All News

From a former patient with cancer lives her dream of working alongside her doctor, to NASCAR crew chief Tommy Baldwin Jr. announcing his cancer diagnosis, this is what’s going on in the oncology space this week.

Progression-free survival improved with Retevmo as the initial treatment for patients with advanced RET-mutant medullary thyroid cancer.

Cancer survivors who consume alcohol may experience worse outcomes, as alcohol usage can interfere with treatment results.

The recent FDA approval of Talvey for heavily pretreated multiple myeloma results in an improved response to therapy and a manageable side effect profile.

Once a friendship turned toxic, I had to put myself first.

“I treat all of my patients like my friends and family,” said Dr. Ravi Munver of Hackensack University Medical Center, who first met Peter Kahan as his honors physics teacher more than 35 years ago.

Cancer survivors who received care plans were more likely to regularly attend cancer-related follow-up care visits, researchers found.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, about the current research in treatments.

As part of its Speaking Out video series, CURE spoke with Dr. Lee Greenberger, chief scientific officer of the Leukemia & Lymphoma Society, who discussed recent treatment advancements and FDA approvals.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

As part of its Speaking Out video series, CURE spoke with Nikki Yuill, oncology social worker and director of the Leukemia & Lymphoma Society’s Information Resource Center, about some of the challenges faced by patients.

The Oncologic Drug Advisory Committee will review data to determine if Lumakras should gain FDA approval for certain patients with KRAS G12C-mutant non-small cell lung cancer.

I became a frequent shopper at the hospital gift shop throughout my cancer experience.

Chemoimmunotherapy was tested in patients with extensive-stage small cell lung cancer to determine its effect based on different performance statuses.

Treatment with Cabometyx plus Tecentriq improved progression-free survival for patients with metastatic castration-resistant prostate cancer.

New PSMA PET/CT can detect signs of prostate cancer within elderly patients without the need of a biopsy.

Patients with nonmetastatic node-positive bladder cancer may have similar survival rates whether they underwent treatment with surgery or radical dose radiotherapy.

I only allow anxiety to take up 15 minutes of my days.

Reporting MPN side effects to the care team, regardless of how “little” they may seem, can help determine how to adjust treatment to address these symptoms, an expert said.

Treatment with Welireg significantly improved progression-free survival rates in patients with advanced renal cell carcinoma, the most common type of kidney cancer.

Patients with prostate cancer may have an inherited or acquired BRCA mutation, and both can have treatment implications, an expert said.

Patients with primary central nervous system lymphoma aged 70 and older may be eligible for Imbruvica as maintenance treatment.

Adults with cancer can benefit from mindfulness-based interventions and other therapies to manage symptoms of anxiety and depression.

Beginning in the long, cold winter of 2022, I began a series of hospitalizations to treat my stage 2 non-specific non-Hodgkin Lymphoma. For the next six months, I would spend a week in the hospital every single month.

Cancer teams can decode and analyze DNA from a patient’s tumor to diagnose the disease, determine personalized treatment plans and assess the response to treatment.

The knowledge of DNA mutations continues to shape the way that breast cancer is treated.

In patients with cancer, psychological distresses such as anxiety and depression are associated with slower time from receiving a diagnosis until the first session of treatment.

Prehabilitation can help patients become eligible for certain cancer treatments, or also help them recover from therapies, while also improving their overall health and fitness, an expert explained.

I am a big believer in the proverbial toolbox.